Conflict of interest: E.A. Tallant and P.E. Gallagher hold a patent for the treatment of cancer with Ang-(1-7). The other authors disclosed no potential conflict of interest.
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis†
Article first published online: 29 MAY 2012
Copyright © 2012 Wiley Periodicals, Inc.
Volume 73, Issue 1, pages 71–82, January 2013
How to Cite
Krishnan, B., Smith, T. L., Dubey, P., Zapadka, M. E., Torti, F. M., Willingham, M. C., Tallant, E. A. and Gallagher, P. E. (2013), Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate, 73: 71–82. doi: 10.1002/pros.22542
- Issue published online: 29 NOV 2012
- Article first published online: 29 MAY 2012
- Manuscript Accepted: 3 MAY 2012
- Manuscript Received: 16 FEB 2012
- The National Institute of Health. Grant Number: HL051952
- GT Cancer Fund, Wake Forest University Comprehensive Cancer Center, Golfers Against Cancer (Greensboro, NC)
- Farley-Hudson Foundation (Jacksonville, NC)
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.